Focus more on quality of end-product


  • Letters
  • Sunday, 04 May 2003

IT is mind-boggling that a major drug manufacturing company like Pan Pharmaceuticals in Australia should be caught for falsifying test results and substituting ingredients in its products.  

It is clear that Canberra’s Therapeutic Goods Administration (TGA) has been ineffective or negligent in its duties to oversee quality of medicines and food supplements produced by Pan Pharmaceuticals.  

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Letters

Concessionaire urged to resolve bottleneck issue
Issue of image rights hits home
Credit due to duo for remarkable rise to form
Long-term solution sought for Forest Heights junction
Heaps of rubbish mar Port Klang’s image
Paving the way to zero food waste
Innovations crucial for sustainable agriculture
Let’s fortify the spirit of tolerance
Goodbye to a great community builder
Bridging divisions through education

Others Also Read